4
Changes in Ownership
BIOGEN INC. Filed Acc 0001127602-24-006213
Head of Pharm Ops and Tech gave up 610 shares (to pay taxes)
- Head of Pharm Ops and Tech acquired 1,260 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Murphy Nicole · Head of Pharm Ops and Tech
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-02-16 | Exercise or conversion : show line 1 in the form | +856 | 9,623.99 | D | ||
| 2024-02-16 | Shares withheld for taxes : show line 2 in the form | −414 | $219.08 | $90,699 | 9,209.99 | D |
| 2024-02-16 | Exercise or conversion : show line 3 in the form | +404 | 9,613.99 | D | ||
| 2024-02-16 | Shares withheld for taxes : show line 4 in the form | −196 | $219.08 | $42,940 | 9,417.99 | D |
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-02-16 | Exercise or conversion : show line 5 in the form Performance Stock Unit | −856 | 0 | D |
| 2024-02-16 | Exercise or conversion : show line 6 in the form Restricted Stock Unit | −404 | 504 | D |
| 2024-02-16 | Other disposition : show line 7 in the form Restricted Stock Unit | −504 | 0 | D |
Loading xslF345X05/form4.xml…